Evidence map›Paper›PMID 26770391›Full record

ArticleInternational journal of clinical and experimental medicine2015

Pharmacokinetic and bioavailability study of angeloylgomisin H in rat plasma by UPLC-MS/MS.

Shanjiang Chen, Zhuyin Jia, Ledan Dong, Peiwu Geng, Zezheng Liu, Suping Yang, Congcong Wen, Fuli Liu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shanjiang ChenDepartment of Cardiology, Wenzhou Central Hospital Wenzhou 325000, Zhejiang, China.
Zhuyin JiaDepartment of Cardiology, Wenzhou Central Hospital Wenzhou 325000, Zhejiang, China.
Ledan DongThe First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000, Zhejiang, China.
Peiwu GengThe Laboratory of Clinical Pharmacy, The People's Hospital of Lishui Lishui 323000, Zhejiang, China.
Zezheng LiuLaboratory Animal Centre, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Suping YangLaboratory Animal Centre, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Congcong WenLaboratory Animal Centre, Wenzhou Medical University Wenzhou 325035, Zhejiang, China.
Fuli LiuThe First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000, Zhejiang, China.
Wenzhou Medical University · CNWenzhou Central Hospital · CNLishui City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angeloylgomisin H, as a major lignin in the fruits, was reported to have the potential to improve insulin-stimulated glucose uptake by activating PPAR-γ. In this work, a sensitive and selective UPLC-MS/MS method for determination of angeloylgomisin H in rat plasma is developed. After addition of rutin as an internal standard (IS), protein precipitation by acetonitrile was used to prepare samples. Chromatographic separation was achieved on a UPLC BEH C18 column (2.1 mm × 100 mm, 1.7 μm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. An electrospray ionization source was applied and operated in positive ion mode; multiple reactions monitoring (MRM) mode was used for quantification using target fragment ions m/z 523.2-315.1 for angeloylgomisin H, and m/z 611.1-303.1 for IS. Calibration plots were linear throughout the range 5-2000 ng/mL for angeloylgomisin H in rat plasma. Mean recoveries of angeloylgomisin H in rat plasma ranged from 86.2% to 92.5%. RSD of intra-day and inter-day precision were both < 11%. The accuracy of the method was between 93.0% and 104.1%. The method was successfully applied to pharmacokinetic study of angeloylgomisin H after either oral or intravenous administration. The absolute bioavailability of angeloylgomisin H was reported as high as 4.9%.

Indexed as

Angeloylgomisin Hpharmacokineticsrat plasmaUPLC-MS/MS

Identifiers

PMID26770391
PMCPMC4694291
OpenAlexW2413907577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.